Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Giant Cells Arteritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07031284
What this trial is testing

Cardiac Involvement in Patients With Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis (GCA)
University Hospital, Bonn 45
Not applicableActive Not RecruitingNCT05703763
What this trial is testing

The Applanation Tonometry in GCA Pilot

Who this might be right for
Giant Cell Arteritis
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 146
Not applicableStudy completedNCT05246540
What this trial is testing

Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
Centre Hospitalier Universitaire Dijon 70
Large-scale testing (Phase 3)WithdrawnNCT03192969
What this trial is testing

Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
Bristol-Myers Squibb
Not applicableStudy completedNCT04390126
What this trial is testing

COVID-19 Related Lockdown Effects On Chronic Diseases

Who this might be right for
Chronic Coronary SyndromeHeart FailureAMD and Macular Edema+5 more
Centre Hospitalier Universitaire Dijon 1,343
Not applicableStudy completedNCT05604482
What this trial is testing

CXCR4-PET/CT for Diagnosing Giant Cell Arteritis

Who this might be right for
VasculitisDiagnoses Disease
Matthias Fröhlich 10
Testing effectiveness (Phase 2)Looking for participantsNCT06335888
What this trial is testing

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Who this might be right for
Giant Cell Arteritis
Insel Gruppe AG, University Hospital Bern 70
Not applicableLooking for participantsNCT06894602
What this trial is testing

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
University Hospital, Brest 100
Not applicableStudy completedNCT03285945
What this trial is testing

FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment

Who this might be right for
Giant Cell Arteritis
University of Aarhus 24
Very early researchUnknownNCT00361192
What this trial is testing

Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis

Who this might be right for
Temporal ArteritisDuplex of Temporal ArteryBiopsy of Temporal Artery
Shaare Zedek Medical Center
Not applicableNot Yet RecruitingNCT07628075
What this trial is testing

Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.

Who this might be right for
Large Vessel VasculitisTakayasu ArteritisGiant Cell Arteritis (GCA)
Imperial College London 18
Not applicableLooking for participantsNCT05854927
What this trial is testing

Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
Fondation Ophtalmologique Adolphe de Rothschild 133
Not applicableEnded earlyNCT04335747
What this trial is testing

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+2 more
Salome Kristensen 53
Not applicableLooking for participantsNCT04102930
What this trial is testing

Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

Who this might be right for
Giant Cell ArteritisPolymyalgia Rheumatica
University of Leeds 4,500
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833411
What this trial is testing

Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone

Who this might be right for
Giant Cell Arteritis (GCA)
Insel Gruppe AG, University Hospital Bern 178
Testing effectiveness (Phase 2)Study completedNCT03812302
What this trial is testing

Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
University of Alberta 9
Not applicableStudy completedNCT02190942
What this trial is testing

VCRC Patient Contact Registry Patient-Reported Data Validation Study

Who this might be right for
Behcet's DiseaseChurg-Strauss SyndromeGiant Cell Arteritis+4 more
University of South Florida 198
Testing effectiveness (Phase 2)Study completedNCT01910038
What this trial is testing

Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.

Who this might be right for
Giant Cell Arteritis
Centre Hospitalier Universitaire Dijon 20
Not applicableActive Not RecruitingNCT04519580
What this trial is testing

Improved Diagnostics and Monitoring of Polymyalgia Rheumatica

Who this might be right for
Polymyalgia RheumaticaGiant Cell ArteritisAdrenal Insufficiency
Kresten Krarup Keller 98
Testing effectiveness (Phase 2)Ended earlyNCT05168475
What this trial is testing

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Who this might be right for
Giant Cell ArteritisTakayasu ArteritisCogan Syndrome+6 more
Cambridge University Hospitals NHS Foundation Trust 22
Next Page